CLINICAL TRIALS PROFILE FOR NOVOLIN L
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
All Clinical Trials for Novolin L
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00071448 ↗ | Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population | Completed | Novo Nordisk A/S | Phase 3 | 2002-06-01 | This trial is conducted in the United States of America (USA). The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients. |
| NCT00487162 ↗ | The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality | Terminated | University of Medicine and Dentistry of New Jersey | N/A | 2007-06-01 | Surgery induces a stress effect on the body partially through a catabolic energy state. In turn, glucose levels may rise to levels which have been associated with major morbidity (Golden, 1999) and mortality (Ouattara, 2005). An increasing body of evidence suggests that intensive insulin therapy for tight control of blood glucose levels in certain surgical and critical care patient populations may improve mortality and selected morbidity outcomes when compared to those patients receiving conventional insulin therapy and blood glucose management. More specifically, poor intra-operative blood glucose control is associated with worse outcome after cardiac surgery. Intensive insulin therapy with tight blood glucose control in surgical patients while in the ICU may reduce morbidity and mortality. Such outcome improvements would clearly provide benefits to patients, providers and payers. To date, there is scant research examining whether intensive insulin therapy for tight control of blood glucose in the perioperative period can alter outcomes for the non cardiac surgery population. The purpose of this study is to determine whether intensive insulin therapy for tight control of blood glucose in the perioperative period in non cardiac major surgery patients is associated with altered morbidity and mortality rates. |
| NCT00522210 ↗ | Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes | Completed | University of Calgary | N/A | 2008-03-01 | The purpose of this study is to determine whether there is a difference in blood sugar control (as measured by hemoglobin A1c (HA1c)), in children given twice daily insulin injections incorporating a new long acting insulin analogue (detemir) compared to children using their current three times a day insulin injections (with intermediate and rapid acting insulin). |
| NCT00593255 ↗ | Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes | Completed | Novo Nordisk A/S | Phase 4 | 2004-07-01 | This trial is conducted in Asia. The aim of this trial is to compare the efficacy of postprandial plasma glucose of two treatment regimens in Chinese subjects. |
| NCT00862875 ↗ | Levemir-Body Composition and Energy Metabolism | Completed | McMaster University | Phase 4 | 2009-03-01 | The objectives is to compare the changes in body composition (primary objective), diabetes parameters, energy expenditure and energy intake between Insulin detemir (Levemir® - Novolin® 4 pen) and insulin glargine (Lantus® - Solostar®) both in combination with Metformin and insulin secretagogues (SU) between baseline and after 6 months of insulin therapy in 80 type 2 diabetic patients failing on oral diabetic agents . |
| NCT00862875 ↗ | Levemir-Body Composition and Energy Metabolism | Completed | Novo Nordisk A/S | Phase 4 | 2009-03-01 | The objectives is to compare the changes in body composition (primary objective), diabetes parameters, energy expenditure and energy intake between Insulin detemir (Levemir® - Novolin® 4 pen) and insulin glargine (Lantus® - Solostar®) both in combination with Metformin and insulin secretagogues (SU) between baseline and after 6 months of insulin therapy in 80 type 2 diabetic patients failing on oral diabetic agents . |
| NCT00862875 ↗ | Levemir-Body Composition and Energy Metabolism | Completed | Institut de Recherches Cliniques de Montreal | Phase 4 | 2009-03-01 | The objectives is to compare the changes in body composition (primary objective), diabetes parameters, energy expenditure and energy intake between Insulin detemir (Levemir® - Novolin® 4 pen) and insulin glargine (Lantus® - Solostar®) both in combination with Metformin and insulin secretagogues (SU) between baseline and after 6 months of insulin therapy in 80 type 2 diabetic patients failing on oral diabetic agents . |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Novolin L
Condition Name
Clinical Trial Locations for Novolin L
Trials by Country
Clinical Trial Progress for Novolin L
Clinical Trial Phase
Clinical Trial Sponsors for Novolin L
Sponsor Name
